Ursa showing brisk monthly sales

Published: 2004-03-08 06:57:00

Updated: 2004-03-08 06:57:00

Daewoong Pharm said recently that Ursa (ursodeoxycholic acid; UDCA) capsule, which has been locally recognized as one of the most popular liver protectives for the past 40 years, has witnessed bigger monthly sales of 3.3 billion won in February than the previous year, and the company is expected ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK